Net Cash Provided by (Used in) Operating Activities |
-82.8K |
USD |
+19.5% |
Q1 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
82.3K |
USD |
-19.8% |
Q1 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
650M |
shares |
|
Q2 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
54M |
shares |
|
Q2 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.75K |
USD |
+99.3% |
Q2 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
14.3M |
USD |
+1.49% |
Q4 2023 |
FY 2024 |
Deferred Tax Assets, Gross |
14.3M |
USD |
+1.49% |
Q4 2023 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
68M |
USD |
+1.49% |
Q4 2023 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2025 |
Preferred Stock, Shares Authorized |
50M |
shares |
|
Q2 2024 |
Q2 2025 |
Additional Paid in Capital |
62.2M |
USD |
|
Q2 2024 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2024 |
Interest Expense |
38.2K |
USD |
-8.67% |
Q2 2024 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2025 |